Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA4 | P22748 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.42 |
| ▸ | CA6 | P23280 | 4/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30829272 | 1.00 | CA2 (0.47) | CA2CA4CA1CA6PDE4A | |
| SCHEMBL27856838 | 0.82 | CA2 (0.44) | CA2CA4CA1CA6AOC3 | |
| SCHEMBL11211183 | 0.82 | AOC3 (0.41) | CA2CA4CA1CA6AOC3 | |
| SCHEMBL1340134 | 0.82 | AOC3 (0.53) | PDE4APDE4BPDE4CPDE4DAOC3 | |
| SCHEMBL194960 | 0.81 | CA2 (0.42) | CA2CA4CA1CA6AOC3 | |
| SCHEMBL30505690 | 0.81 | PDE4A (0.42) | CA2CA4CA1CA6PDE4A | |
| SCHEMBL6805249 | 0.81 | CA2 (0.42) | CA2CA4CA1CA6AOC3 | |
| SCHEMBL2024931 | 0.81 | CA2 (0.49) | CA2CA4CA1CA6PDE4A | |
| SCHEMBL31681726 | 0.80 | KDM4E (0.50) | MEN1KMT2AKDM4E | |
| SCHEMBL11210250 | 0.79 | CYP3A4 (0.50) | CA2CA4CA1CA6PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113559904-B | Application of nitrogen-carbon material anchored iron single-atom catalyst in catalyzing ammoxidation of alcohol to prepare nitrile | 南京理工大学 | 2024-04-02 | — | — | CN | claimed |
| CN-113559904-A | Application of nitrogen-carbon material anchored iron monatomic catalyst in reaction for catalyzing ammoxidation of alcohol to prepare nitrile | 南京理工大学 | 2021-10-29 | — | — | CN | claimed |
| CN-105001107-B | A kind of method of synthesizing methyl Hongmaoxinjian | 西安交通大学 | 2016-08-17 | — | — | CN | claimed |
| CN-105001107-A | Synthetic method for methyl caulophine | UNIV XI AN JIAOTONG | 2015-10-28 | — | — | CN | claimed |
| US-20250154106-A1 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | NATIONAL INSTITUTES OF HEALTH | 2025-05-15 | — | — | US | disclosed |
| US-12221419-B2 | Abietanes and methods of making and using the same | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2025-02-11 | — | — | US | disclosed |
| EP-4499055-A2 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | The Florida State University Research Foundation, Incorporated (US) | 2025-02-05 | — | — | EP | disclosed |
| US-20240140912-A1 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | NATIONAL INSTITUTES OF HEALTH | 2024-05-02 | — | — | US | disclosed |
| CN-113559904-B | Application of nitrogen-carbon material anchored iron single-atom catalyst in catalyzing ammoxidation of alcohol to prepare nitrile | 南京理工大学 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023192921-A2 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INCORPORATED (US) | 2023-10-05 | — | — | WO | disclosed |
| CN-113559904-A | Application of nitrogen-carbon material anchored iron monatomic catalyst in reaction for catalyzing ammoxidation of alcohol to prepare nitrile | 南京理工大学 | 2021-10-29 | — | — | CN | disclosed |
| CN-105001107-B | A kind of method of synthesizing methyl Hongmaoxinjian | 西安交通大学 | 2016-08-17 | — | — | CN | disclosed |
| US-20130109713-A1 | ANTIMICROBIAL AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY | 2013-05-02 | — | — | US | disclosed |
| US-20120059026-A1 | ANTIMICROBIAL AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120059026-A1 | ANTIMICROBIAL AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2011163610-A2 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-12-29 | — | — | WO | disclosed |
| WO-2011159926-A1 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011156626-A1 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2010127307-A1 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-11-04 | — | — | WO | disclosed |
| WO-2010127307-A1 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109713-A1 | ANTIMICROBIAL AGENTS | RPS4X, RPS4Y1, MRPL21 | CA2 2798/4885CA4 2634/4885CA1 4586/4885 |
| US-20120059026-A1 | ANTIMICROBIAL AGENTS | ZYX, Q6ZSR9, ZC3HAV1L | CA2 1379/4885CA4 413/4885CA1 3802/4885 |
| US-20250154106-A1 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | SYMPK, TXK, HYPK | CA2 2614/4885CA4 1312/4885CA1 1373/4885 |
| US-20240140912-A1 | ABIETANES AND METHODS OF MAKING AND USING THE SAME | SYMPK, TXK, HYPK | CA2 2614/4885CA4 1312/4885CA1 1373/4885 |
| US-12221419-B2 | Abietanes and methods of making and using the same | SYMPK, TXK, HYPK | CA2 2614/4885CA4 1312/4885CA1 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.